![logo](/logos/002898.SZ.webp)
Sailong Pharmaceutical Group Co., Ltd.
SZSE:002898.SZ
14.85 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Sailong Pharmaceutical Group Co., Ltd. |
Symbool | 002898.SZ |
Munteenheid | CNY |
Prijs | 12.44 |
Beurswaarde | 2,189,440,000 |
Dividendpercentage | 0% |
52-weken bereik | 9.88 - 17.2 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Zhang Xu |
Website | https://www.sailong.cn |
An error occurred while fetching data.
Over Sailong Pharmaceutical Group Co., Ltd.
Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)